Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wellstein

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1986
Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assayA Wellstein, D Palm, G G Belz, et al.
International Journal of Cancer|April 17, 2001
An FGF-binding protein (FGF-BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF-2 releaseA Aigner, M Butscheid, P Kunkel, et al.
Biochemical Pharmacology|November 15, 2000
Differential regulation of a fibroblast growth factor-binding protein by receptor-selective analogs of retinoic acidB J Boyle, V K Harris, E D Liaudet-Coopman, et al.
The Journal of Biological Chemistry|July 21, 1998
Phorbol ester-induced transcription of a fibroblast growth factor-binding protein is modulated by a complex interplay of positive and negative regulatory promoter elementsV K Harris, E D Liaudet-Coopman, B J Boyle, et al.
Cancer Research|March 15, 1993
Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cellsY E Shi, J Torri, L Yieh, et al.
Der Anaesthesist|March 1, 1978
[Clinical and laboratory aspects of malignant hyperthermia in children with special reference to creatine kinase isoenzymes (author's transl)]H Blume, E W Schmidt, S Cayuela, et al.
The Journal of Biological Chemistry|May 1, 2001
Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cellsH J List, K J Lauritsen, R Reiter, et al.
The American Journal of Physiology|February 1, 1988
Differentiation of beta 1- and beta 2-adrenoceptor-mediated effects in humansO E Brodde, A Daul, A Wellstein, et al.
The Journal of Biological Chemistry|February 7, 2001
Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathwaysV K Harris, C M Coticchia, B L Kagan, et al.
The Journal of Investigative Dermatology|September 1, 1999
Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1G A Mashour, H L Wang, R Cabal-Manzano, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Journal of Cardiovascular Pharmacology|January 1, 1986
Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assayA Wellstein, D Palm, G G Belz, et al.
International Journal of Cancer|April 17, 2001
An FGF-binding protein (FGF-BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF-2 releaseA Aigner, M Butscheid, P Kunkel, et al.
Biochemical Pharmacology|November 15, 2000
Differential regulation of a fibroblast growth factor-binding protein by receptor-selective analogs of retinoic acidB J Boyle, V K Harris, E D Liaudet-Coopman, et al.
The Journal of Biological Chemistry|July 21, 1998
Phorbol ester-induced transcription of a fibroblast growth factor-binding protein is modulated by a complex interplay of positive and negative regulatory promoter elementsV K Harris, E D Liaudet-Coopman, B J Boyle, et al.
Cancer Research|March 15, 1993
Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cellsY E Shi, J Torri, L Yieh, et al.
Der Anaesthesist|March 1, 1978
[Clinical and laboratory aspects of malignant hyperthermia in children with special reference to creatine kinase isoenzymes (author's transl)]H Blume, E W Schmidt, S Cayuela, et al.
The Journal of Biological Chemistry|May 1, 2001
Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cellsH J List, K J Lauritsen, R Reiter, et al.
The American Journal of Physiology|February 1, 1988
Differentiation of beta 1- and beta 2-adrenoceptor-mediated effects in humansO E Brodde, A Daul, A Wellstein, et al.
The Journal of Biological Chemistry|February 7, 2001
Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathwaysV K Harris, C M Coticchia, B L Kagan, et al.
The Journal of Investigative Dermatology|September 1, 1999
Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1G A Mashour, H L Wang, R Cabal-Manzano, et al.
Pageof 11